Lyric

Descriptive rather than critical, and unusual in that the underlying asset is not a platform but a rules corpus: over 30 years of pre payment editing content built as ClaimsXten since 1989. Machine learning and predictive analytics genuinely improve prioritization, audit targeting, and orchestration, and Replay applies AI to select which claims are worth auditing. But the payment decisions themselves rest on codified policy and clinical rules, and the company describes decisions as grounded in policy and expert clinical review. A plan buys the rules and the accumulated policy content first; the AI decides where to point them.

The stated design goal is payment decisions that are independent, verified, and explainable, grounded in policy and expert clinical review, which places a documented rationale behind each determination rather than an opaque score. Explainability matters more here than in most categories, because a payment decision a plan cannot justify becomes a provider dispute. Held back from A because the boundary between automated action and human review is not published: pre payment editing that automatically adjusts or denies a claim is consequential, and the company does not state which determinations execute without review. That is the same gap flagged for Banjo Health, and the same question Cohere Health answers explicitly.

The strongest third party validation in the payer side cluster: named 2025 Best in KLAS for Pre payment Accuracy and Integrity, which is a buyer survey result rather than a vendor claim, in a category KLAS only began covering in October 2023. Reported scale of more than 100 payers with stated retention, against a business operating since 1989, is a durability signal that recent entrants cannot match. Replay productivity figures of up to 3x and 4x findings are vendor stated and should be treated as such.

Integration is aimed at payer core systems rather than EHRs, which is correct for this buyer. The distinguishing architectural claim is that Lyric42 delivers the advantages of a multi vendor payment integrity strategy through a single integration, so a plan can use several specialist vendors without maintaining separate connections to each. Held back from A because named core administrative systems and integration specifics were not retrieved.

No public pricing. Contact the vendor. Enterprise agreements with health plans. Payment integrity is frequently sold on contingency against recoveries rather than licence, and that distinction materially changes vendor incentives, so buyers should establish the model. The company positions Replay partly as reducing dependence on external audit vendors, which implies a licence rather than contingency posture, but this was not confirmed.

Precisely bounded to health plan payment accuracy across both pre payment and post payment activity: claims editing, fraud waste and abuse detection, DRG validation, coordination of benefits review, itemized bill analysis, and audit automation. No claims outside payer operations.